Artigo Produção Nacional Revisado por pares

Cancer risk‐reducing surgery: Brazilian Society of Surgical Oncology Guideline Part 2 (Gastrointestinal and thyroid)

2022; Wiley; Volume: 126; Issue: 1 Linguagem: Inglês

10.1002/jso.26813

ISSN

1096-9098

Autores

Vandré Cabral Gomes Carneiro, Ana C. L. V. C. Gifoni, Bernard Rossi, Carlos Eduardo Mattos da Cunha Andrade, Fernanda Teresa de Lima, Henrique de Campos Reis Galvão, José Cláudio Casali da Rocha, Leonardo Silveira da Silva Barreto, Patrícia Ashton‐Prolla, Rodrigo Santa Cruz Guindalini, Terence Pires de Farias, Wesley Pereira Andrade, Paulo Henrique de Sousa Fernandes, Reitan Ribeiro, André Lopes, Audrey Tieko Tsunoda, Bruno Roberto Braga Azevedo, Carlos Augusto Martinez Marins, Diego Oliveira, Evandro Airton Sordi dos Santos, Felipe José Fernández Coimbra, Francisco Alcides Dias Filho, Francisco Carlos de Oliveira Lopes, Francisco G. Fernandes, Guilherme Fonteles Ritt, Gustavo Andreazza Laporte, Gustavo Cardoso Guimarães, Heládio Feitosa e Castro Neto, Jocela Cristina dos Santos, Jordana Botelho de Carvalho Vilela, G�mez-Marin Jorge, Juliano Rodrigues da Cunha, Leonardo Medeiros Milhomem, Luciana M. da Silva, Luiza de Freitas Maciel, Nathalia Moreira Ramalho, Rafael Leite Nunes, Rodrigo Guido de Araújo, Rogério de Assunção Ehrhardt, Ronald Enrique Delgado Bocanegra, C. S. Tyrone, Viviane Rezende de Oliveira, Walyson Silva Surimã, Miriam de Melo Melquiades, Héber Salvador de Castro Ribeiro, Alexandre Ferreira Oliveira,

Tópico(s)

Colorectal and Anal Carcinomas

Resumo

Abstract Background Risk‐reducing operations are an important part of the management of hereditary predisposition to cancer. In selected cases, they can considerably reduce the morbidity and mortality associated with cancer in this population. Objectives The Brazilian Society of Surgical Oncology (BSSO) developed this guideline to establish national benchmarks for cancer risk‐reducing operations. Methods The guideline was prepared from May to December 2021 by a multidisciplinary team of experts to discuss the surgical management of cancer predisposition syndromes. Eleven questions were defined and assigned to expert groups that reviewed the literature and drafted preliminary recommendations. Following a review by the coordinators and a second review by all participants, the groups made final adjustments, classified the level of evidence, and voted on the recommendations. Results For all questions including risk‐reducing colectomy, gastrectomy, and thyroidectomy, a major agreement was achieved by the participants, always using accessible alternatives. Conclusion This and its accompanying article represent the first guideline in cancer risk reduction surgery developed by the BSSO and it should serve as an important reference for the management of families with cancer predisposition.

Referência(s)